SLC10A2 and fatty liver disease: Treatment with an IBAT inhibitor significantly improved hepatic steatosis in high-fat diet mice, and fecal microbiome transplantation using stool from high-fat diet plus IBAT inhibitor mice prevented hepatic steatosis caused by a high-fat diet [99,100].